Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Cells ; 10(2)2021 02 23.
Article in English | MEDLINE | ID: mdl-33672328

ABSTRACT

Current gold-standard strategies for bone regeneration do not achieve the optimal recovery of bone biomechanical properties. To bypass these limitations, tissue engineering techniques based on hybrid materials made up of osteoprogenitor cells-such as mesenchymal stem cells (MSCs)-and bioactive ceramic scaffolds-such as calcium phosphate-based (CaPs) bioceramics-seem promising. The biological properties of MSCs are influenced by the tissue source. This study aims to define the optimal MSC source and construct (i.e., the MSC-CaP combination) for clinical application in bone regeneration. A previous iTRAQ analysis generated the hypothesis that anatomical proximity to bone has a direct effect on MSC phenotype. MSCs were isolated from adipose tissue, bone marrow, and dental pulp, then cultured both on a plastic surface and on CaPs (hydroxyapatite and ß-tricalcium phosphate), to compare their biological features. On plastic, MSCs isolated from dental pulp (DPSCs) presented the highest proliferation capacity and the greatest osteogenic potential. On both CaPs, DPSCs demonstrated the greatest capacity to colonise the bioceramics. Furthermore, the results demonstrated a trend that DPSCs had the most robust increase in ALP activity. Regarding CaPs, ß-tricalcium phosphate obtained the best viability results, while hydroxyapatite had the highest ALP activity values. Therefore, we propose DPSCs as suitable MSCs for cell-based bone regeneration strategies.


Subject(s)
Bone Regeneration/physiology , Mesenchymal Stem Cells/metabolism , Adult , Alkaline Phosphatase/metabolism , Bone Regeneration/drug effects , Calcium Phosphates/pharmacology , Cell Survival/drug effects , Durapatite/pharmacology , Female , Humans , Isotope Labeling , Male , Mesenchymal Stem Cells/drug effects , Middle Aged , Osteogenesis/drug effects , Plastics
2.
Updates Surg ; 72(4): 1201-1206, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32382958

ABSTRACT

Administration of botulinum toxin (BTX) is being used in cases of complex ventral hernia for the reconstruction of the linea alba and closure of the abdominal wall. However, there are no published results regarding the long-term effects of BTX and its implication in hernia recurrence. Our purpose is to evaluate the outcomes in hernia recurrence of the administration of BTX in complex ventral hernia repair. 36 patients underwent elective surgery for complex ventral hernia and were evaluated retrospectively. The study included patients with a transverse hernia defect ≥ 100 mm and loss of domain hernias, receiving BTX injections 6 weeks prior to elective surgery. Global results and long-term recurrence were analysed. There were no complications related to BTX administration. The mean transverse hernia defect was 139.44 ± 50.98 mm, the mean abdominal cavity volume (ACV) was 10.19 ± 3.33 dm3, the mean hernia sac volume (HSV) was 1.93 ± 1.79 dm3, presenting a mean volume ratio (VR) of 20.71 ± 19.76%. Primary closure was achieved in 28 patients (77.8%), 21 of whom (75%) needed an anterior component separation technique. Recurrence rate was 11.4% at 2-years follow-up. BTX administration is a safe and feasible method for abdominal wall expansion prior to complex incisional hernia repair, achieving high rates of primary closure. Long-term follow-up shows good results in terms of recurrence in these patients.


Subject(s)
Abdominal Wall/surgery , Botulinum Toxins, Type A/administration & dosage , Hernia, Ventral/surgery , Herniorrhaphy/methods , Incisional Hernia/surgery , Abdominal Cavity/pathology , Aged , Elective Surgical Procedures/methods , Feasibility Studies , Female , Follow-Up Studies , Humans , Male , Middle Aged , Recurrence , Retrospective Studies , Time Factors , Treatment Outcome
3.
J Gastrointest Surg ; 12(12): 2103-8; discussion 2108-9, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18820977

ABSTRACT

INTRODUCTION: We report the final analysis of a prospective single-blinded randomized trial designed to investigate whether omission of preoperative mechanical bowel preparation increases the rate of surgical-site infection and anastomotic failure after elective colon surgery with intraperitoneal anastomosis by a single surgeon. PATIENTS AND METHODS: Patients scheduled to undergo an elective colon or proximal rectal resection with a primary anastomosis by a single surgeon were randomized to receive either oral polyethylene glycol (Group A) or no mechanical bowel preparation (Group B). Patients were followed by an independent surgeon. RESULTS: One hundred and forty nine patients were enrolled. Three patients (2%) were preoperatively excluded because of active immunosuppression and 13 (9%) were excluded from the final analysis. Of the remaining 129 patients, 65 were assigned to Group A and 64 to Group B. Thirty patients (23.2%) developed wound infection, (Group A = 24.6% and Group B = 17.2%; NS). There were three cases of intra-abdominal sepsis a (Group A 4.6%). The anastomotic failure rate was 5.4% (n = 7), four patients in Group A (6.2%) vs. three patients in Group B (4.7%) (NS). When SSI and anastomotic failure were combined, the complication rate in Group A was 35.4% vs. 21.9% for Group B. The NNH was 7.4. CONCLUSION: Our final analysis shows that a single surgeon will not have a higher rate of either surgical-site infection or anastomotic failure if he/she routinely omits preoperative mechanical bowel preparation.


Subject(s)
Anastomosis, Surgical/methods , Colonic Diseases/surgery , Polyethylene Glycols/administration & dosage , Preoperative Care/methods , Surgical Wound Infection/prevention & control , Aged , Chi-Square Distribution , Female , Humans , Male , Prospective Studies , Single-Blind Method , Surgical Wound Infection/etiology , Treatment Failure , Treatment Outcome
4.
J Gastrointest Surg ; 11(5): 562-7, 2007 May.
Article in English | MEDLINE | ID: mdl-17394048

ABSTRACT

We report an interim analysis of a prospective single-blinded randomized trial designed to investigate whether preoperative mechanical bowel preparation influences the rate of surgical-site infection and anastomotic failure after elective colorectal surgery with primary intraperitoneal anastomosis performed by a single surgeon. Patients scheduled to undergo an elective colorectal procedure with a primary intraperitoneal anastomosis were randomized to receive either oral polyethylene glycol lavage solution and enemas (group A) or no preparation (group B). Surgical-site infection and anastomotic failure were investigated. Of 97 patients included, 48 were assigned to group A and 49 to group B. Twelve (12.4%) developed wound infections, six in each group (12.5 vs. 12.2%; NS). Intra-abdominal sepsis was only seen in group A (n = 3, 6.3%). Anastomotic failure occurred in four patients in group A (8.3%) vs. two patients in group B (4.1%) (NS). The overall complication rate in group A was 27.1%, vs. 16.3% in group B. The number needed to harm was 9.3. Our interim analysis of a prospective single-blinded randomized trial suggests that a surgeon may have the same or even worse outcomes when mechanical bowel preparation is routinely used for colorectal surgery with primary intraperitoneal anastomosis.


Subject(s)
Anastomosis, Surgical/methods , Cathartics , Colonic Diseases/surgery , Enema , Preoperative Care , Rectal Diseases/surgery , Abdomen , Aged , Aged, 80 and over , Anastomosis, Surgical/adverse effects , Cathartics/administration & dosage , Cutaneous Fistula/etiology , Elective Surgical Procedures , Feces , Female , Follow-Up Studies , Humans , Intestinal Fistula/etiology , Male , Polyethylene Glycols/administration & dosage , Prospective Studies , Sepsis/etiology , Single-Blind Method , Surgical Wound Dehiscence/etiology , Surgical Wound Infection/etiology , Therapeutic Irrigation
SELECTION OF CITATIONS
SEARCH DETAIL
...